A new report, now available on ASDReports, forecasts the world IVD market will reach $122.9bn in 2027. That revenue prediction and others appear in Medical Devices Leader Series - Top In Vitro Diagnostics (IVD) Companies 2017-2027: Leading IVD Companies in the US, Europe and Asia published in November 2016.
The key player estimates that in 2016, Big Pharma companies, namely Roche, Danaher and Siemens dominated the sector accounting for 41.5% of the global IVD market with combined revenue of $25.7bn
This report analyses the leading companies operating in the in vitro diagnostics (IVD) market. It aims to provide a comprehensive review of those companies, looking at their IVD products, financial performance, deals with other drug developers and future outlooks. The study examines opportunities and challenges in the industry and market for IVD products, as well as strategies for future growth. To provide context for the company profiles, this report also contains analysis of the world IVD market. An estimate for the market size is provided for 2016, and overall market revenues are forecasted for the period 2017 to 2027. Additionally, there is an analysis of the leading IVD segments.
The report focuses on these main segments of the market: